Skip to main content

Find Clinical Trials

Home
Conditions
Anemia, Refractory

Clinical trial condition

Anemia, Refractory

Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.

188 public trials 35 recruiting studies

Refine in advanced search Browse all conditions

Anemia, Refractory trial results

Not Yet Recruiting

Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantation

NCT07214064

Conditions: AML (Acute Myeloid Leukemia), Anemia, Anemia, Refractory, +12 more
Locations: University Hospital , Department of Internal Medicine II Tübingen, Baden-Wurttemberg, Germany

View Trial Details

Not Yet Recruiting

Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation

NCT07025824

Conditions: AML - Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +11 more
Locations: Medizinische Fakultät der TU Dresden, Medizinische Klinik und Poliklinik I Dresden, Germany

Universitätsmedizin Halle (Saale) Halle, Germany

Universitätsklinikum Schleswig-Holstein, Campus Kiel Kiel, Germany

Universitätsklinikum Münster, Medizinische Klinik A, KMT-Zentrum Münster, Germany

View Trial Details

Completed

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

NCT03480360

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +33 more
Locations: Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center Lebanon, New Hampshire, United States

View Trial Details

Completed

Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission

NCT00093470

Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monocytic Leukemia, +31 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

Kaiser Permanente-San Diego Mission San Diego, California, United States

View all 341 locations

View Trial Details

Completed

Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer

NCT00534430

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +27 more
Locations: Not specified

View Trial Details

Completed

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

NCT02220985

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
Locations: University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

NCT01203722

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +14 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations

NCT01911871

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +13 more
Locations: Hôpital Necker Enfants Malades Paris, France

View Trial Details

Completed

Efficacy and Safety of Luspatercept: a Study by Fondazione Italiana Sindromi Mielodisplastiche

NCT05520749

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +5 more
Locations: Istituto Clinico Humanitas Milan, Rozzano, Italy

View Trial Details

Completed

Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care

NCT04212390

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +5 more
Locations: IRCCS Humanitas Research Hospital Rozzano, Milano, Italy

Elena Crisà Candiolo, Torino, Italy

View Trial Details